Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PEOPLE - New board member for AspenBio Pharma

Dr Mark Ratain is a new independent member of the board of directors of Aspen BioPharma. The company is dedicated to the development of novel drugs and diagnostics for animals and humans. Dr Ratain, the seventh director to be appointed, is a hematologist/oncologist and clinical pharmacologist. Aspen BioPharma's chairman Greg Pusey comments: "Dr Ratain joins us at an exciting period in the development of AspenBio's appendicitis test and single-chain animal products. We look forward to benefiting from his extensive experience as we work to bring these products to market."


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts